Medicare Enrolled

Dr. Mohsen Ali, MD

Neurology · San Dimas, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1330 W COVINA BLVD, San Dimas, CA 91773
9095922145
In practice since 2006 (20 years)
NPI: 1750359071 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ali

Dr. Mohsen Ali is a neurology specialist in San Dimas, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ali performed 2,865 Medicare services across 1,639 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ali received a total of $7,101 from 46 pharmaceutical and/or device companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in CA $7,101 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,865
Medicare services
Top 18% in CA for neurology
1,639
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~143 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,102 $96 $181
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
566 $95 $175
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
315 $121 $287
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
256 $82 $192
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
179 $137 $338
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
167 $63 $130
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
116 $362 $661
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
59 $211 $450
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
37 $188 $400
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
36 $147 $283
New patient office visit, complex (60-74 min) 19 $164 $350
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
13 $253 $475
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,101
Total received (2018-2024)
Avg $1,014/year across 7 years
Top 27% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
377
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,708 (94.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$393 (5.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,525
2023
$1,557
2022
$1,205
2021
$694
2020
$699
2019
$586
2018
$835

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$563
PFIZER INC.
$207
Grifols USA, LLC
$171
ARGENX US, INC.
$136
Alexion Pharmaceuticals, Inc.
$75
Celgene Corporation
$71
Lilly USA, LLC
$64
Takeda Pharmaceuticals U.S.A., Inc.
$56
UCB, Inc.
$47
Otsuka America Pharmaceutical, Inc.
$42
Lundbeck LLC
$29
MDD US Operations, LLC
$25
Novartis Pharmaceuticals Corporation
$23
SCILEX PHARMACEUTICALS INC.
$17
Top 3 companies account for 61.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$958
Amgen Inc.
$681
AbbVie Inc.
$673
Teva Pharmaceuticals USA, Inc.
$446
ARGENX US, INC.
$336
UCB, Inc.
$329
Allergan, Inc.
$304
PFIZER INC.
$271
Novartis Pharmaceuticals Corporation
$267
Biogen, Inc.
$262
Janssen Pharmaceuticals, Inc
$236
Akcea Therapeutics, Inc.
$205
Grifols USA, LLC
$200
Biohaven Pharmaceuticals, Inc.
$174
Lilly USA, LLC
$154
Alexion Pharmaceuticals, Inc.
$137
US WorldMeds, LLC
$133
Kyowa Kirin, Inc.
$107
Allergan Inc.
$105
Sunovion Pharmaceuticals Inc.
$97
Otsuka America Pharmaceutical, Inc.
$96
Takeda Pharmaceuticals U.S.A., Inc.
$93
Celgene Corporation
$88
IMPEL PHARMACEUTICALS INC.
$81
MDD US Operations, LLC
$68
Biohaven Pharmaceutical Holding Company Ltd.
$67
Eisai Inc.
$49
Abbott Laboratories
$49
Promius Pharma LLC
$48
Acorda Therapeutics, Inc
$45
GENZYME CORPORATION
$43
Scilex Pharmaceuticals Inc.
$32
Lundbeck LLC
$29
EISAI INC.
$29
Neurelis, Inc.
$28
Shire North American Group Inc
$23
Adamas Pharmaceuticals, Inc.
$22
Genentech USA, Inc.
$21
Supernus Pharmaceuticals, Inc.
$19
Vertical Pharmaceuticals, LLC
$19
Catalyst Pharmaceuticals, Inc.
$18
SCILEX PHARMACEUTICALS INC.
$17
AQUESTIVE THERAPEUTICS, INC.
$17
Impax Laboratories, Inc.
$14
Retrophin, Inc.
$9
Travere Therapeutics, Inc.
$2
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Briviact · Cholbam · EMGALITY · Enspryng · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · INBRIJA · INFINITY · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · MAYZENT · NOURIANZ · NURTEC ODT · Neupro · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OSMOLEX ER · OXTELLAR XR · Ponvory · QULIPTA · REXULTI · RYTARY · Rystiggo · SOLIRIS · SYMPAZAN · TECFIDERA · TEGSEDI · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Xadago · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in San Dimas?
Compare neurologists in the San Dimas area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
292
Per 100K population
3.0
County median income
$87,760
Nearest hospital
SAN DIMAS COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ali is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ali experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ali performed 1,102 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $7,101 from 46 companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ali's costs compare to other neurologists in San Dimas?
Dr. Ali's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →